NXSTAGE MEDICAL, INC.
Manufacturer adverse-event records for NXSTAGE MEDICAL, INC. come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2002–2026 · thin-book · elevated Death-code · injury-heavy
Volume signature
NXSTAGE MEDICAL, INC. is a thinner MAUDE footprint
NXSTAGE MEDICAL, INC. accounts for 3,542 FDA MAUDE reports (#443 of 443, thin-book tercile). Death-coded event_type share is 5.05% (elevated); Injury share 66.9% (injury-heavy).
What the volume reading shows for NXSTAGE MEDICAL, INC.
The standout signal for NXSTAGE MEDICAL, INC. is filing volume: 3,542 adverse-event reports in FDA MAUDE (#443 of 443, thin-book). Death-coded event_type share sits at 5.05% (elevated).
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 12 device types, led in this extract by Injury at 2,369 (66.9% of event_type total). Peak single-year volume reaches 689 reports across 24 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (12)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.